Power testing partnership, NASH breakthrough designation, and new CEO appointments. What’s new for pharma in business?

Fujifilm Toyama's influenza treatment passes COVID-19 trial.

Most clinical trials against COVID-19 exclude the very patients most at risk from the disease.

How will new guidance issued by the FDA affect drug importation?

GlaxoSmithKline has launched a vaccine awareness campaign in the USA as immunization rates drop amidst the pandemic.

Nominations are now open for The Medicine Maker 2021 Power List.

Can genomic medicine usher in a new era of curative treatments for neurological diseases? Experts from Sangamo give their views.

A breakthrough in transgenic mice opens the door to “Humabodies.”

Drug development needs to move more rapidly, but not at the expense of safety.

Single-use systems have come a long way. We look at experience with the technology so far.